Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/VIR-BIOTECHNOLOGY-INC-66771988/attualita/Vir-Biotechnology-Inc-annuncia-la-somministrazione-del-primo-partecipante-al-nuovo-studio-di-Fase-44886243/?utm_source=whatsapp&utm_medium=social&utm_campaign=share